Last reviewed · How we verify
Microbiome restoration - FMT
At a glance
| Generic name | Microbiome restoration - FMT |
|---|---|
| Also known as | Fecal Microbiota Transplantation |
| Sponsor | Professor Klaus Bønnelykke |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Effect of Gut Microbiome Intervention on Aging Via Oral FMT (EARLY_PHASE1)
- Assessing the Tolerance and Clinical Benefit of feCAl tranSplantation in patientS With melanOma (PHASE2)
- STOP-CDI: Efficacy of Fecal Microbiota Transplantation vs Fidaxomicin vs Vancomycin in Treating and Preventing Relapse of Clostridioides Difficile Infection (NA)
- Restoration of Antibiotics Related Infant Microbiota Perturbations by Autologous Fecal Transplant (PHASE1)
- Restoration of the Gut Microbiome After Cesarean Section (PHASE1)
- Sentinel Cohort REACT (PHASE1)
- Effect of Gut Microbiome Restoration on Primary Hypertension Via FMT (EARLY_PHASE1)
- Gut Microbiome in Biliary Atresia
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Microbiome restoration - FMT CI brief — competitive landscape report
- Microbiome restoration - FMT updates RSS · CI watch RSS
- Professor Klaus Bønnelykke portfolio CI